CClinicalTrials.gg
CompletedNCT01688687pCLEUpdated Sep 20, 2012

Conventional Biopsies vs pCLE for Diagnosis of Superficial Gastric Neoplasia

An observational study in Early Gastric Cancer and Gastric Dysplasia, sponsored by Soonchunhyang University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2012-09-20.

Sponsored by Soonchunhyang University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
63
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Confocal endomicroscopy (CLE) allows real-time in-vivo high-resolution and high-magnification imaging of the gastrointestinal epithelium, which is comparable to histopathology. Previous studies have investigated the accuracy of pCLE for diagnosis and differentiated of colorectal polyps, Barrett's esophagus and pancreaticobiliary strictures. However, to date there are limited data exploring the application of pCLE to gastric lesions, and this is the first study comparing the diagnosis of conventional forceps biopsy with that of pCLE using the final specimens obtained from endoscopic resection as a reference standard. The aims of this study were (1) the accuracy of pCLE compared to conventional forceps biopsy using histopathology results following endoscopic resection as a reference, and (2) comparison of "real time" in-vivo pCLE diagnosis with that of blinded "off-line" pCLE diagnosis, and off-line interobserver agreement.

02

Conditions studied

  • Early Gastric Cancer
  • Gastric Dysplasia

Browse trials for

03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 63 is below the median of 204 across 1,683 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Soonchunhyang University Hospital is the lead sponsor of 61 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Consecutive patients referred to a tertiary medical center for endoscopic resection of gastric superficial lesions.

Inclusion criteria

  • Patients with biospy proven superficial gastric neoplasia, suitable for endoscopic resection.

Exclusion criteria

Exclusion Criteria:

  • Patients with uncorrectable coagulopathy,
  • liver cirrhosis,
  • acute gastrointestinal bleeding,
  • pregnancy,
  • breast feeding,
  • documented allergy to fluorescein,
  • patients with lesions that were deemed unsuitable for endoscopic resection, and
  • patients without documented conventional biopsy results.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
63 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • Superficial gastric neoplasia

    Patients with superficial gastric neoplasia on diagnostic endoscopy, recieved both conventional endoscopic forcpes biopsies and pCLE. All patients were subject to endoscopic resection of the lesion.

    Procedure: Endoscopic submucosal dissection

Interventions

  • ProcedureEndoscopic submucosal dissection
06

What researchers measure

Primary outcomes

  1. The accuracy of pCLE compared to conventional forceps biopsy

    The accuracy of pCLE compared to conventional forceps biopsy was assessed using histopathology results following endoscopic resection as a reference

    Time frame: in-vivo pCLE accuracy compared to conventional forceps biopsy was assessed 1-2 weeks prior to endoscopic resection.

Secondary outcomes

  1. Comparison of "real time" in-vivo pCLE diagnosis with that of blinded "off-line" pCLE diagnosis.

    Time frame: 1-3 months after endoscopic resection and final histopathological analysis

  2. Off-line pCLE interobserver agreement

    Time frame: 1-3 months after endoscopic resection and final histopathological analysis

07

Study locations

1 site
  • Soonchunhyang University Seoul Hospital
    Seoul, 140-743, Korea, Republic of
08

References and documents

Publications

  • Wallace M, Lauwers GY, Chen Y, Dekker E, Fockens P, Sharma P, Meining A. Miami classification for probe-based confocal laser endomicroscopy. Endoscopy. 2011 Oct;43(10):882-91. doi: 10.1055/s-0030-1256632. Epub 2011 Aug 4. PubMed 21818734 ↗
  • Jeon SR, Cho WY, Jin SY, Cheon YK, Choi SR, Cho JY. Optical biopsies by confocal endomicroscopy prevent additive endoscopic biopsies before endoscopic submucosal dissection in gastric epithelial neoplasias: a prospective, comparative study. Gastrointest Endosc. 2011 Oct;74(4):772-80. doi: 10.1016/j.gie.2011.05.005. Epub 2011 Jul 29. PubMed 21802680 ↗
  • Shahid MW, Buchner AM, Raimondo M, Woodward TA, Krishna M, Wallace MB. Accuracy of real-time vs. blinded offline diagnosis of neoplastic colorectal polyps using probe-based confocal laser endomicroscopy: a pilot study. Endoscopy. 2012 Apr;44(4):343-8. doi: 10.1055/s-0031-1291589. Epub 2012 Mar 1. PubMed 22382851 ↗
  • Wallace MB, Crook JE, Saunders M, Lovat L, Coron E, Waxman I, Sharma P, Hwang JH, Banks M, DePreville M, Galmiche JP, Konda V, Diehl NN, Wolfsen HC. Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett's esophagus. Gastrointest Endosc. 2012 Sep;76(3):539-47.e1. doi: 10.1016/j.gie.2012.05.004. Epub 2012 Jun 28. PubMed 22749368 ↗
  • Kuiper T, Kiesslich R, Ponsioen C, Fockens P, Dekker E. The learning curve, accuracy, and interobserver agreement of endoscope-based confocal laser endomicroscopy for the differentiation of colorectal lesions. Gastrointest Endosc. 2012 Jun;75(6):1211-7. doi: 10.1016/j.gie.2012.01.040. Epub 2012 Mar 28. PubMed 22459661 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 20, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01688687
Lead sponsor
Soonchunhyang University Hospital
Responsible party
Gene Hyun Bok (M.D., Soonchunhyang University Hospital) — Principal investigator
First posted
Sep 20, 2012
Start date
Feb 2012
Primary completion
Sep 2012
Last update
Sep 20, 2012

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion